Publication | Open Access
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study
35
Citations
20
References
2021
Year
These data support the use of D-Vd in Chinese patients with RRMM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1